Tobacco company scientist gained access to WHO collaborating center

	Tweet

A new study of previously confidential tobacco industry documents shows that a Philip Morris scientist established close connections with a WHO Collaborating Centre in Thailand called the Chulabhorn Research Institute (CRI). The study is published in this week’s PLoS Medicine.

The CRI is an internationally renowned teaching institution for a variety of scientific disciplines, including environmental toxicology (the study of how chemicals in the environment, such as tobacco smoke, can affect human health). The institute is designated a WHO Collaborating Centre, carrying out activities in support of the WHO’s public health programs.

Ross MacKenzie (School of Public Health, University of Sydney, Australia) and Jeff Collin (Centre for International Public Health Policy, University of Edinburgh, Scotland) analyzed tobacco company documents that were made publicly available online following litigation in the United States. Philip Morris documents revealed that ostensibly independent overseas scientists, now identified as industry consultants, were able to gain access to the Thai scientific community. Most significantly, a Philip Morris scientist called Roger Walk established close connections with the CRI. 

Documents indicate that Walk was able to use such links to influence the study and teaching of environmental toxicology in the institute and to develop relations with key officials and local scientists so as to advance the interests of Philip Morris within Thailand and across Asia.

The CRI is headed by Professor Dr Her Royal Highness Princess Chulabhorn, the daughter of the King of Thailand. “While sensitivities surrounding royal patronage of the CRI make public criticism extremely difficult,” say MacKenzie and Collin, “indications of ongoing involvement by tobacco industry consultants suggest the need for detailed scrutiny of such relationships.”

The link between Philip Morris and the CRI found in this study raises the possibility that the tobacco industry is managing to influence medical research and teaching at an academic institution allied with the WHO. The WHO has stated that a firewall is in place between itself and the tobacco industry—but the study authors argue, based on their findings, that ‘’this firewall is not impenetrable.’’

The study findings, they conclude, highlight a challenge posed to international tobacco control efforts, especially with respect to Article 5.3 of an international treaty called the WHO Framework Convention on Tobacco Control. Article 5.3 addresses the need to protect public health policies from the vested interests of the tobacco industry. The authors say that better safeguards must be put in place to prevent tobacco companies from thwarting public health goals.

###

Citation: MacKenzie R, Collin J (2008) “A good personal scientific relationship”: Philip Morris scientists and the Chulabhorn Research Institute, Bangkok. PLoS Med 5(12): e238. doi:10.1371/journal.pmed.0050238

CONTACT
Jeff Collin
Centre for International Public Health Policy
University of Edinburgh
UK
TEL: +44 131 651 3961
FAX: +44 131 651 3762

Ross MacKenzie
School of Public Health
University of Sydney
Australia
TEL: +61 2 9351 7789
FAX: +61 2 9351 7420


Contact: Andrew Hyde

44-122-346-3330
Public Library of Science

RELATED STORIES:
You are never too old to quit smoking, say King’s Lynn couple   NAFLD Patients Have Increased Risk for Poor Outcomes After Liver Transplant   Google Can Help Doctors Diagnose Difficult Cases   New Bird Flu Outbreak Reported in Thailand   Fitness Levels Decline With Age, Especially After 45   Moscow bans night-time vodka sales in health drive   Partial smoking ban seen as lacking   Researcher Hopes for FDA Action Against Alcoholic Energy Drinks   Smoking may increase risk of multiple sclerosis   Stopping Harmful Oral Bacteria in Their Path   Doctors, Nurses Often Use Holistic Medicine for Themselves   Nicotine replacement therapies may not be effective in helping people quit smoking

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]